معرفی
Katie Healy is a researcher at the Department of Laboratory Medicine, Karolinska Institutet, affiliated with the VIVAC research group under Matti Sällberg. She holds a PhD in Medical Science (2022) from the Department of Dental Medicine.
- Postdoctoral Researcher, 2022-2025
- Affiliated to Research, 2025-2026
Her research focuses on MAIT cells in cancer immunotherapy and viral infection contexts. Key areas include immune response profiling, microbiome interactions, and TCR-engineered cell therapy, particularly in SARS-CoV-2 vaccination responses and hepatitis/pancreatic cancer settings.
Recent publications analyze MAIT cell dynamics in HIV, CLL patients, and HBV-HCC, with methodological contributions to clinical-scale TCR-T manufacturing. Her work bridges immunology, microbiome studies, and cell therapy.
Scientific awards include the 2023 Sven Gard Scholarship for virology research. Current grants include a Swedish Research Council project (2022-2025) on MAIT cell immunotherapy through type-17/type-1 signaling modulation.
